Michael Castellano - BlackRock Health Independent Trustee
| BME Etf | USD 39.89 0.48 1.22% |
Mr. Michael J. Castellano serves as Independent Trustee of BlackRock Health Science Trust. Mr. Castellano is Chief Financial Officer of Lazard Group LLC from 2001 to 2011 Chief Financial Officer of Lazard Ltd from 2004 to 2011 Director, Support Our Aging Religious from 2009 to June 2015 Director, National Advisory Board of Church Management at Villanova University since 2010 Trustee, Domestic Church Media Foundation since 2012 Director, CircleBlack Inc. since 2015. The Boards benefit from Mr. Castellanos career in accounting which spans over forty years. Mr. Castellano has served as Chief Financial Officer of Lazard Ltd. and as a Managing Director and Chief Financial Officer of Lazard Group. Prior to joining Lazard, Mr. Castellano held various senior management positions at Merrill Lynch Co., including Senior Vice President Chief Control Officer for Merrill Lynchs capital markets businesses, Chairman of Merrill Lynch International Bank and Senior Vice President Corporationrationrate Controller. Prior to joining Merrill Lynch Co., Mr. Castellano was a partner with Deloitte Touche where he served a number of investment banking clients over the course of his 24 years with the firm. Mr. Castellanos knowledge of financial and accounting matters qualifies him to serve as a member of each Funds Audit Committee. Mr. Castellanos independence from the Funds and the Funds investment advisor enhances his service as a member of the Audit Committee, Governance Committee and Performance Oversight Committee.
| Age | 75 |
| Tenure | 13 years |
| Address | 50 Hudson Yards, New York, NY, United States, 10001 |
| Phone | 212 810 5300 |
| Web | https://www.blackrock.com/investing/products/24022 |
BlackRock Health Management Efficiency
BlackRock Health's management efficiency ratios could be used to measure how well BlackRock Health manages its routine affairs as well as how well it operates its assets and liabilities.Management Performance
| Return On Equity | 0.0337 | ||||
| Return On Asset | 0.0021 |
BlackRock Health Sciences Money Managers
| CFA CFA, Portfolio Mang | ||
| Erin Xie, Portfolio Manager | ||
| Robert Hubbard, Independent Trustee | ||
| Karen Robards, Independent Vice Chairman of the Board of Trustees | ||
| Richard Cavanagh, Independent Co-Chairman of the Board of Trustees | ||
| Charles Park, Chief Compliance Officer and Anti- Money Laundering Officer | ||
| Frank Fabozzi, Independent Trustee | ||
| J Holloman, Independent Trustee | ||
| Janey Ahn, Secretary | ||
| John Perlowski, President, Chief Executive Officer, Trustee | ||
| Michael Castellano, Independent Trustee | ||
| Xiang Liu, Portfolio Manager | ||
| Cynthia Egan, Independent Trustee | ||
| Kyle CFA, Portfolio Manager | ||
| Jay Fife, Treasurer | ||
| Jonathan Diorio, Vice President | ||
| Robert Fairbairn, Trustee | ||
| Christopher Accettella, Portfolio Manager | ||
| Thomas CFA, Portfolio Manager | ||
| Trent Walker, Chief Financial Officer | ||
| Catherine Lynch, Independent Trustee | ||
| Jeffrey Lee, Portfolio Manager | ||
| Stayce Harris, Independent Trustee | ||
| W Kester, Independent Trustee |
BlackRock Etf Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right etf is not an easy task. Is BlackRock Health a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0337 | ||||
| Return On Asset | 0.0021 | ||||
| Profit Margin | 2.44 % | ||||
| Operating Margin | 0.21 % | ||||
| Current Valuation | 556.29 M | ||||
| Shares Outstanding | 13.94 M | ||||
| Shares Owned By Institutions | 22.00 % | ||||
| Number Of Shares Shorted | 5 K | ||||
| Price To Earning | 6.69 X | ||||
| Price To Book | 0.91 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BlackRock Health Sciences. Also, note that the market value of any etf could be tightly coupled with the direction of predictive economic indicators such as signals in population. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
The market value of BlackRock Health Sciences is measured differently than its book value, which is the value of BlackRock that is recorded on the company's balance sheet. Investors also form their own opinion of BlackRock Health's value that differs from its market value or its book value, called intrinsic value, which is BlackRock Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because BlackRock Health's market value can be influenced by many factors that don't directly affect BlackRock Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between BlackRock Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if BlackRock Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BlackRock Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.